The role of neutrophils in vasospasm and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: Is it time for a SAH clinical trial targeting neutrophils?
Open Access
- 8 September 2025
- journal article
- review article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 45 (12) , 2269-2282
Abstract
Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating neurological disease, and one of the primary drivers of morbidity after aneurysm rupture is the phenomenon of delayed cerebral ischemia (DCI). Significant knowledge has been gained over the past two decades of the impact of neuroinflammation in DCI; and neutrophils are now believed to play a major role. There is significant human subject data showing the rise of neutrophil related inflammatory markers and neutrophil’s association with poor outcome after aSAH, but as of yet no trials involving human subjects have been done specifically targeting neutrophils. There is however a growing body of evidence in animals models that targeting neutrophils, or their byproducts such as neutrophil extracellular traps improves outcomes. This review summarizes the available evidence of neutrophil’s impact in both human subjects and animal models of aSAH and should serve as an impetuous to explore clinical trials in human subjects.Keywords
This publication has 116 references indexed in Scilit:
- Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primatesJournal of Neurosurgery, 2003
- Fasudil, a protein kinase inhibitor, prevents the development of endothelial injury and neutrophil infiltration in a two-haemorrhage canine subarachnoid model.1999
- Mechanisms That Regulate the Function of the Selectins and Their LigandsPhysiological Reviews, 1999
- Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhageJournal of Neurosurgery, 1998
- Monoclonal Antibodies Against ICAM-1 and CD18 Attenuate Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in RabbitsStroke, 1998
- Cisternal CSF levels of cytokines after subarachnoid hemorrhageNeurological Research, 1998
- Cytokine production in cerebrospinal fluid after subarachnoid haemorrhageNeurological Research, 1995
- Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1992
- Serum Albumin Level on Admission as a Predictor of Death, Length of Stay, and ReadmissionArchives of internal medicine (1960), 1992
- THE BLOOD LEEUCOCYTE COUNT AND ITS PROGNOSTIC SIGNIFICANCE IN SUBARACHNOID HæMORRHAGEBrain, 1974